Skip to main content
CDC Website

Progress Toward Elimination of Mother-to-Child Transmission of Hepatitis B Virus — Region of the Americas, 2012–2022

This report outlines the progress made toward the elimination of mother-to-child transmission of hepatitis B virus in the Region of the Americas from 2012 to 2022. It highlights key strategies, achievements, and challenges in achieving the goal of reducing the transmission rates, providing a comprehensive overview of regional efforts to combat this public health issue.

Hepatitis B Vaccine (Interim) VIS

This webpage provides the Vaccine Information Statement (VIS) for the hepatitis B vaccine, detailing the vaccine's purpose, the diseases it prevents, the recommended vaccination schedule, potential side effects, and important information for healthcare providers. It serves as an essential resource for understanding the importance of hepatitis B vaccination.

Policies for Expanding Hepatitis C Testing and Treatment in United States Prisons and Jails

This report proposes policies for expanding access to hepatitis C (HCV) testing and treatment in United States jails and prisons. The report's policy recommendations draw principally from settlement agreements, judicial opinions, and other filings in those cases, supplemented by current medical guidance and input from public health experts, medical professionals, and advocates.

Acerca de Doxy-PEP (About Doxy-PEP)

This information sheet provides details on Doxy PEP (Post-Exposure Prophylaxis) as a preventive treatment for sexually transmitted infections (STIs), including syphilis, gonorrhea, and chlamydia. It outlines the necessary steps for individuals who have been exposed to an STI and may be eligible for doxycycline PEP.

About Doxy-PEP

This information sheet provides details on Doxy PEP (Post-Exposure Prophylaxis) as a preventive treatment for sexually transmitted infections (STIs), including syphilis, gonorrhea, and chlamydia. It outlines the necessary steps for individuals who have been exposed to an STI and may be eligible for doxycycline PEP.

Early or “Acute” HIV Mouth Sores Pictures

This webpage provides information on early HIV-related mouth sores, including pictures to help with identification. It discusses common oral symptoms associated with early HIV infection, such as ulcers, thrush, and other lesions, and highlights their significance in early diagnosis. 

Opportunity to Strengthen Access to Hepatitis C Treatment Through Section 1115 Justice-Involved Reentry Initiative Demonstrations

This report lays out the required sections that must be included in a state’s Section 1115 Demonstration application and identifies where and how a state can be explicit about its intent to address the health care needs of individuals with hepatitis C as part of its Justice-Involved Reentry Initiative.

What You Need to Know About the New Hepatitis C Test

This article highlights a new hepatitis C test that delivers rapid results without requiring a separate lab visit, improving access to early diagnosis and treatment. It emphasizes the importance of expanding testing efforts, particularly for high-risk populations, to support hepatitis C elimination. The article underscores the need for continued innovation in screening technologies to reduce barriers to care and prevent long-term health complications like liver disease and cancer.

Learn the Facts About Tuberculosis (TB)

This information sheet provides essential information about tuberculosis (TB), including its causes, how it spreads, and the differences between latent TB infection (LTBI) and active TB disease. It outlines testing methods, treatment options, and the importance of early diagnosis and adherence to treatment to prevent transmission.

Cervical Cancer Screening Includes New Self-Collection Method for HPV Testing

This article discusses how the U.S. Preventive Services Task Force has proposed new draft guidelines for cervical cancer screening, allowing women aged 30 and older to self-collect HPV samples. This approach aims to improve access to screening, particularly for Black and Hispanic women. The guidelines recommend HPV testing every five years for women aged 30 to 65, alongside traditional Pap tests, and the self-collection method is expected to increase screening rates by offering a more comfortable option.

Was this page helpful? Give Feedback